Effect of the anti-TNF agents, adalimumab, etanercept, infliximab, and certolizumab pegol (CDP870) on the induction of apoptosis in activated peripheral blood lymphocytes and monocytes. - Fossati,G.; Nesbit,AM.. (Am J Gastroenterol, 2005)